esorubicin has been researched along with Lymph Node Metastasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crivellari, D; Di Pietro, N; Frustaci, S; Galligioni, E; Gasparini, G; Lo Re, G; Monfardini, S; Tirelli, U | 1 |
1 other study(ies) available for esorubicin and Lymph Node Metastasis
| Article | Year |
|---|---|
Phase II trial of esorubicin in patients with advanced melanoma.
Topics: Adult; Aged; Doxorubicin; Drug Evaluation; Humans; Lymphatic Metastasis; Melanoma; Middle Aged | 1987 |